InvestorsHub Logo
Followers 6
Posts 896
Boards Moderated 0
Alias Born 12/23/2015

Re: pearsby09 post# 9367

Wednesday, 01/18/2017 12:31:21 AM

Wednesday, January 18, 2017 12:31:21 AM

Post# of 233519
Just to be clear on this, P3 has a much greater success rate than P2. Most trials fail in P2. I would like to add that when trials incorporate biomarkers (as ours do) that greatly increases the odds of success in P3, a 77% success rate across all categories.

http://www.biopharminternational.com/clinical-development-success-rates-examined-new-bio-report
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News